These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 7934340

  • 21. Mesalazine as maintenance treatment in Crohn's disease.
    Vos J, Lesterhuis W.
    Gastroenterology; 1994 Feb; 106(2):553-4. PubMed ID: 8299923
    [No Abstract] [Full Text] [Related]

  • 22. Second trial of mesalamine therapy in the treatment of active Crohn's disease.
    Singleton J.
    Gastroenterology; 1994 Aug; 107(2):632-3. PubMed ID: 8039647
    [No Abstract] [Full Text] [Related]

  • 23. The effect of mesalamine and nicotine in the treatment of inflammatory bowel disease.
    Bonapace CR, Mays DA.
    Ann Pharmacother; 1997 Aug; 31(7-8):907-13. PubMed ID: 9220055
    [Abstract] [Full Text] [Related]

  • 24. [Crohn disease in childhood].
    Bender SW, Kirchmann H, Posselt HG.
    Wien Klin Wochenschr; 1986 Aug 29; 98(16):520-7. PubMed ID: 2876556
    [Abstract] [Full Text] [Related]

  • 25. [5-Aminosalicylic acid in ulcerative colitis and Crohn's disease (author's transl)].
    Maier K, Fischer C, Klotz U, Heinkel K.
    Dtsch Med Wochenschr; 1982 Jul 23; 107(29-30):1131-4. PubMed ID: 6123426
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Maintenance strategies in Crohn's disease.
    Sachar DB.
    Hosp Pract (1995); 1996 Jan 15; 31(1):99-106. PubMed ID: 8595995
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Aminosalicylates in chronic inflammatory intestinal diseases and rheumatoid arthritis].
    Maier KP.
    Dtsch Med Wochenschr; 1992 Oct 16; 117(42):1614-5. PubMed ID: 1356747
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease.
    Klotz U, Maier K, Fischer C, Heinkel K.
    N Engl J Med; 1980 Dec 25; 303(26):1499-502. PubMed ID: 6107853
    [Abstract] [Full Text] [Related]

  • 33. Leukotrienes in Crohn's disease: effect of sulfasalazine and 5-aminosalicylic acid.
    Dreyling KW, Hoppe U, Peskar BA, Schaarschmidt K, Peskar BM.
    Adv Prostaglandin Thromboxane Leukot Res; 1987 Dec 25; 17A():339-43. PubMed ID: 2889333
    [No Abstract] [Full Text] [Related]

  • 34. Treatment of Crohn's disease with 5-ASA.
    Katz J.
    Am J Gastroenterol; 1993 Sep 25; 88(9):1315-7. PubMed ID: 8362823
    [No Abstract] [Full Text] [Related]

  • 35. [New developments in the treatment of inflammatory bowel diseases. What is certain?].
    Feurle GE.
    Z Gastroenterol Verh; 1990 Apr 25; 25():150-2. PubMed ID: 1694355
    [No Abstract] [Full Text] [Related]

  • 36. [Conservative therapy of Crohn disease--reliable measures based on clinical studies].
    Hartmann F, Plauth M.
    Internist (Berl); 1991 Sep 25; 32(9):518-23. PubMed ID: 1683663
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Maintaining remission of Crohn's disease.
    Novak E.
    CMAJ; 1988 Jul 01; 139(1):14. PubMed ID: 3383034
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.